These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 19917058)
1. Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma. Tatsuwaki H; Tanigawa T; Watanabe T; Machida H; Okazaki H; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Muguruma K; Sawada T; Hirakawa K; Higuchi K; Arakawa T Cancer Sci; 2010 Feb; 101(2):550-8. PubMed ID: 19917058 [TBL] [Abstract][Full Text] [Related]
2. Correlation of 15-prostagladin dehydrogenase expression with clinicopathological factors and survival rate in gastric adenocarcinoma. Seo SH; Kang MS; Kim KH; An MS; Ha TK; Bae KB; Oh MK; Choi CS; Oh SH; Choi YK Int J Surg; 2015 Jan; 13():96-101. PubMed ID: 25704623 [TBL] [Abstract][Full Text] [Related]
3. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167 [TBL] [Abstract][Full Text] [Related]
4. 15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human gastric cancer. Liu Z; Wang X; Lu Y; Du R; Luo G; Wang J; Zhai H; Zhang F; Wen Q; Wu K; Fan D Cancer Biol Ther; 2010 Oct; 10(8):780-7. PubMed ID: 20699658 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 induces loss of 15-hydroxyprostaglandin dehydrogenase in early gastric tubular adenocarcinoma. Park YS; Lee JH; Jung DB; Kim HB; Jung JH; Pak S; Ryu YM; Park HJ; Park YY; Jung HY; Myung SJ Sci Rep; 2018 Dec; 8(1):17717. PubMed ID: 30531928 [TBL] [Abstract][Full Text] [Related]
6. Expression of 15-PGDH is downregulated by COX-2 in gastric cancer. Liu Z; Wang X; Lu Y; Han S; Zhang F; Zhai H; Lei T; Liang J; Wang J; Wu K; Fan D Carcinogenesis; 2008 Jun; 29(6):1219-27. PubMed ID: 18174234 [TBL] [Abstract][Full Text] [Related]
7. Decreased expression of 15-hydroxyprostaglandin dehydrogenase in gastric carcinomas. Jang TJ; Ji YS; Jung KH Yonsei Med J; 2008 Dec; 49(6):917-22. PubMed ID: 19108014 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of 15-hydroxyprostaglandin dehydrogenase by Helicobacter pylori in human gastric carcinogenesis. Ryu YM; Myung SJ; Park YS; Yang DH; Song HJ; Jeong JY; Lee SM; Song M; Kim DH; Lee HJ; Park SK; Fink SP; Markowitz SD; Jung KW; Kim KJ; Ye BD; Byeon JS; Jung HY; Yang SK; Kim JH Cancer Prev Res (Phila); 2013 Apr; 6(4):349-59. PubMed ID: 23430757 [TBL] [Abstract][Full Text] [Related]
9. Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease. Dai L; King DW; Perera DS; Lubowski DZ; Burcher E; Liu L Dig Dis Sci; 2015 May; 60(5):1236-46. PubMed ID: 25666316 [TBL] [Abstract][Full Text] [Related]
10. 15-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma. Lou LH; Jing DD; Lai YX; Lu YY; Li JK; Wu K World J Gastroenterol; 2012 Mar; 18(10):1028-37. PubMed ID: 22416177 [TBL] [Abstract][Full Text] [Related]
11. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells. Tong M; Ding Y; Tai HH Carcinogenesis; 2006 Nov; 27(11):2170-9. PubMed ID: 16632868 [TBL] [Abstract][Full Text] [Related]
12. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression. Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544 [TBL] [Abstract][Full Text] [Related]
13. Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors. Pham H; Chen M; Li A; King J; Angst E; Dawson DW; Park J; Reber HA; Hines OJ; Eibl G Pancreas; 2010 Apr; 39(3):332-9. PubMed ID: 19820419 [TBL] [Abstract][Full Text] [Related]
14. 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line. Quidville V; Segond N; Lausson S; Frenkian M; Cohen R; Jullienne A Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):14-30. PubMed ID: 16997128 [TBL] [Abstract][Full Text] [Related]
15. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs). Tai HH; Chi X; Tong M Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448 [TBL] [Abstract][Full Text] [Related]
17. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer. Monteleone NJ; Moore AE; Iacona JR; Lutz CS; Dixon DA Sci Rep; 2019 Apr; 9(1):5405. PubMed ID: 30931980 [TBL] [Abstract][Full Text] [Related]
18. Colon tumour cells increase PGE(2) by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation. Roberts HR; Smartt HJ; Greenhough A; Moore AE; Williams AC; Paraskeva C Carcinogenesis; 2011 Nov; 32(11):1741-7. PubMed ID: 21926111 [TBL] [Abstract][Full Text] [Related]
19. 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer. Hu M; Li K; Maskey N; Xu Z; Peng C; Tian S; Li Y; Yang G Int J Clin Exp Pathol; 2015; 8(6):6910-8. PubMed ID: 26261578 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas. Arima K; Ohmuraya M; Miyake K; Koiwa M; Uchihara T; Izumi D; Gao F; Yonemura A; Bu L; Okabe H; Imai K; Hashimoto D; Baba Y; Chikamoto A; Yamashita YI; Furukawa T; Araki K; Baba H; Ishimoto T Oncogene; 2019 Feb; 38(8):1211-1224. PubMed ID: 30250298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]